What does Protara Therapeutics, Inc. do?
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive…
What is Protara Therapeutics, Inc.'s P/E and P/B ratio?
Protara Therapeutics, Inc. has a P/E ratio of -1.8 and a P/B ratio of 0.89.
What is Protara Therapeutics, Inc.'s debt-to-equity ratio?
Protara Therapeutics, Inc. has a debt-to-equity ratio of 0.02.
How much does Protara Therapeutics, Inc. owe compared with what it owns?
Protara Therapeutics, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Protara Therapeutics, Inc.'s Positivity rank?
Protara Therapeutics, Inc. is ranked #1,967 of 6,774 companies globally and #525 of 4,000 in United States on PositoAI, with a Positivity Score of 22,066.
Does Protara Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Protara Therapeutics, Inc..
Where can I read the latest news about Protara Therapeutics, Inc.?
Recent headlines about Protara Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Protara Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Protara Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.